Open | $127.730 |
Close | $128.140 |
Volume / Avg. | 838.241K / 1.030M |
Day Range | 126.460 - 128.210 |
52 Wk Range | 119.590 - 148.620 |
Market Cap | $14.186B |
P/E Ratio | 17.108 |
Dividend Yield | 2.340% |
Exchange | NYSE |
RSI | 51 |
Short Interest | 3.53% |
Days to Cover | 2.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Quest Diagnostics (NYSE: DGX) through any online brokerage.
Other companies in Quest Diagnostics’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Privia Health Gr (NASDAQ:PRVA).
The latest price target for Quest Diagnostics (NYSE: DGX) was reported by Leerink Partners on Monday, February 26, 2024. The analyst firm set a price target for 135.00 expecting DGX to rise to within 12 months (a possible 5.35% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Quest Diagnostics (NYSE: DGX) is $128.14 last updated March 18, 2024 at 7:00 PM EDT.
The next Quest Diagnostics (DGX) dividend date is projected to be Friday, April 5, 2024.
Quest Diagnostics’s Q1 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for Quest Diagnostics.
Quest Diagnostics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.